Anti-Complement C5 Antibody (olendalizumab)
Catalog No.
F1202
Anti-Complement C5 Antibody (Lendalizumab)
Featured Products
Lendalizumab (Anti-Complement C5) is a proprietary antibody targeting complement protein C5a with potential immunomodulatory and anti-inflammatory activities. Molecular weight: 146.02KD.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1337966-73-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Lendalizumab, ALXN1007, ALXN-1007
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01031
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
Complement C5
Please avoid freeze-thaw cycles.